SCHEMBL19906412

SCHEMBL19906412

Cc1cc2nc(-c3ccc4c(c3)OCCO4)sc2c(-c2ccc(Cl)cc2OC(C)(C)C)c1CC(=O)O

nearest known ligand 0.38

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
TP53 P04637 6/20 0.38
MAPT P10636 4/20 0.38
KDM4E B2RXH2 3/20 0.37
MEN1 O00255 3/20 0.37
KMT2A Q03164 3/20 0.37
ALDH1A1 P00352 2/20 0.37
PTGDR2 Q9Y5Y4 1/20 0.37
LMNA P02545 3/20 0.37
PPARD Q03181 2/20 0.36
SLC16A3 O15427 1/20 0.35
SLC16A1 P53985 1/20 0.35
NPC1 O15118 1/20 0.35
RAB9A P51151 1/20 0.35
SMN1; SMN2 Q16637 2/20 0.34
SLC6A9 P48067 1/20 0.33
PTGER3 P43115 1/20 0.33
PIK3CG P48736 1/20 0.33
POLB P06746 1/20 0.33
SHMT2 P34897 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19906413 0.86 MAPT (0.43) TP53MAPTKDM4EMEN1KMT2A
SCHEMBL19906108 0.84 CPT1A (0.35) TP53MAPTKDM4EMEN1KMT2A
SCHEMBL19906394 0.84 GRM5 (0.36) KDM4EMEN1KMT2AALDH1A1PTGDR2
SCHEMBL19906107 0.83 CPT1A (0.32) KDM4EMEN1KMT2AALDH1A1PTGDR2
SCHEMBL19906119 0.82 PTGDR2 (0.39) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL19905892 0.82 PTGDR2 (0.37) MAPTKDM4EMEN1KMT2AALDH1A1
SCHEMBL19906142 0.82 PRF1 (0.37) KDM4EMEN1KMT2AALDH1A1PTGDR2
SCHEMBL19906137 0.82 PTGDR2 (0.39) KDM4EMEN1KMT2AALDH1A1PTGDR2
SCHEMBL19906135 0.82 CHRM2 (0.35)
SCHEMBL19905897 0.81 MAPT (0.39) MAPTKDM4EMEN1KMT2AALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3070081-B1 BENZOTHIAZOL-6-YL ACETIC ACID DERIVATIVES AND THEIR USE FOR TREATING AN HIV INFECTION GILEAD SCIENCES INC (US) 2018-02-28 EP disclosed